Medios Technologies

Medios Technologies

Software development company creating deep learning software to assist doctors in grading fundus images for detection of diabetic retinopathy, a type of blindness causes by disease related changes in the vasculature of the retina.

All edits

Edits on 29 January, 2020
Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 29 January, 2020 4:16 pm
Edits made to:
Article (+20/-20 characters)

Article

The technology uses an AI assistant to help any physician detect diabetic retinopathydiabetic retinopathy in the absence of a specialist with the goal of early detection for preventing blindness. Screening for diabetic retinopathy before symptoms occur, can prevent blindness.

Edits on 9 October, 2019
Meredith Hanel
Meredith Hanel edited on 9 October, 2019 6:42 pm
Edits made to:
Timeline (+1 events) (+199 characters)

Timeline

October 9, 2019

Diagnostic Accuracy of Community-Based Diabetic Retinopathy Screening With an Offline Artificial Intelligence System on a Smartphone. - PubMed - NCBI

Analysis of the performance of Medios AI (Remidio)

Meredith Hanel
Meredith Hanel edited on 9 October, 2019 6:39 pm
Edits made to:
Article (+22/-11 characters)

Article

MEDIOS-AI is an AI integrated retinal imaging device that uses the Remidio smartphone. TheA study of the feasibility of using this smartphone-based retinal camera with in-built offline artificial intelligence algorithm to screen for diabetic retinopathy has beenwas published in 2019 JAMA Opthalmology. More than 1300 patients with diabetes mellitus were screened by a team from Aditya Jyot Foundation for Twinling Little Eyes, Mumbae, led by Dr. Natarajan, who is President of the All India Opthalmology Society. Diagnostic accuracy of MEDIOS-AI to detect referable diabetic retinopathy was validated. The AI provides a report in less than 10 seconds. The platform could be extended to other sight-threatening chronic diseases such as glaucoma.

Meredith Hanel
Meredith Hanel edited on 9 October, 2019 6:32 pm
Edits made to:
Article (+804 characters)

Article

The technology uses an AI assistant to help any physician detect diabetic retinopathy in the absence of a specialist with the goal of early detection for preventing blindness. Screening for diabetic retinopathy before symptoms occur, can prevent blindness.

...

MEDIOS-AI is an AI integrated retinal imaging device that uses the Remidio smartphone. The feasibility of using this smartphone-based retinal camera with in-built offline artificial intelligence algorithm to screen for diabetic retinopathy has been published in JAMA Opthalmology. More than 1300 patients with diabetes mellitus were screened by a team from Aditya Jyot Foundation for Twinling Little Eyes, Mumbae, led by Dr. Natarajan, who is President of the All India Opthalmology Society. Diagnostic accuracy of MEDIOS-AI to detect referable diabetic retinopathy was validated. The AI provides a report in less than 10 seconds. The platform could be extended to other sight-threatening chronic diseases such as glaucoma.

Edits on 25 June, 2019
Golden AI
Golden AI approved a suggestion from Golden's AI on 25 June, 2019 4:17 am
Edits made to:
Infobox (+4 properties)
People (+1 rows) (+2 cells) (+17 characters)

People

Name
Role
Related Golden topics

Medios HR

Employee

Infobox

Edits on 30 April, 2019
Marcin Brook
Marcin Brook approved a suggestion from Golden's AI on 30 April, 2019 8:38 pm
Edits made to:
Article (+9/-9 characters)

Article

Co-founder Bhargav Sosale is a software engineer and product designer who graduated from Nanyang Technological University, SingaporeSingapore and whose father, mother and sister are diabetes doctors. Co-founder Florian Savoy is an expert in computer vision with research experience at University of Illinois and a degree from École polytechnique fédérale de Lausanne, Switzerland. India is planned to be the company’s first market and the diagnosis will cost $1. Medios is partnered with retinal camera companies including Remidio and Intuvision.

Andrey Pyankov
Andrey Pyankov approved a suggestion from Golden's AI on 30 April, 2019 7:56 pm
Edits made to:
Article (+5/-5 characters)

Article

Co-founder Bhargav Sosale is a software engineer and product designer who graduated from Nanyang Technological University, Singapore and whose father, mother and sister are diabetes doctors. Co-founder Florian Savoy is an expert in computer vision with research experience at University of Illinois and a degree from École polytechnique fédérale de Lausanne, Switzerland. IndiaIndia is planned to be the company’s first market and the diagnosis will cost $1. Medios is partnered with retinal camera companies including Remidio and Intuvision.

Edits on 26 April, 2019
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 26 April, 2019 8:28 pm
Edits made to:
Article (+8/-8 characters)

Article

Co-founder Bhargav Sosale is a software engineer and product designer who graduated from Nanyang Technological University, Singapore and whose father, mother and sister are diabetes doctors. Co-founder Florian Savoy is an expert in computer vision with research experience at University of Illinois and a degree from École polytechnique fédérale de LausanneLausanne, Switzerland. India is planned to be the company’s first market and the diagnosis will cost $1. Medios is partnered with retinal camera companies including Remidio and Intuvision.

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 26 April, 2019 6:10 pm
Edits made to:
Article (+11/-11 characters)

Article

Co-founder Bhargav Sosale is a software engineer and product designer who graduated from Nanyang Technological University, Singapore and whose father, mother and sister are diabetes doctors. Co-founder Florian Savoy is an expert in computer vision with research experience at University of Illinois and a degree from École polytechnique fédérale de Lausanne, SwitzerlandSwitzerland. India is planned to be the company’s first market and the diagnosis will cost $1. Medios is partnered with retinal camera companies including Remidio and Intuvision.

Edits on 24 April, 2019
Meredith Hanel
Meredith Hanel edited on 24 April, 2019 2:03 pm
Edits made to:
Infobox (+1 properties)

Infobox

Meredith Hanel
Meredith Hanel edited on 24 April, 2019 1:51 pm
Edits made to:
Infobox (+11 properties)
Description (+231 characters)
Article (+713 characters)
People (+2 rows) (+4 cells) (+48 characters)
Documentaries, videos and podcasts (+1 rows) (+2 cells) (+83 characters)
Categories (+1 topics)
Topic thumbnail

Medios Technologies

Software development company creating deep learning software to assist doctors in grading fundus images for detection of diabetic retinopathy, a type of blindness causes by disease related changes in the vasculature of the retina.

Article

The technology uses an AI assistant to help any physician detect diabetic retinopathy in the absence of a specialist with the goal of early detection for preventing blindness.

...

Co-founder Bhargav Sosale is a software engineer and product designer who graduated from Nanyang Technological University, Singapore and whose father, mother and sister are diabetes doctors. Co-founder Florian Savoy is an expert in computer vision with research experience at University of Illinois and a degree from École polytechnique fédérale de Lausanne, Switzerland. India is planned to be the company’s first market and the diagnosis will cost $1. Medios is partnered with retinal camera companies including Remidio and Intuvision.

People

Name
Role
Related Golden topics

Bhargav Sosale

Co-founder

Florian Savoy

Co-founder

Documentaries, videos and podcasts

Title
Date
Link

Medios Technologies - EFSG2 Investor Day

Infobox

Categories

Meredith Hanel"Initial topic creation"
Meredith Hanel created this topic on 24 April, 2019 1:16 pm
Edits made to:
Topic thumbnail

 Medios Technologies

Software development company creating deep learning software to assist doctors in grading fundus images for detection of diabetic retinopathy, a type of blindness causes by disease related changes in the vasculature of the retina.

No more activity to show.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.